Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 81-94 of 94
- Global Neurology Academy
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
- Interviews
Optimizing MS Treatment Options
- Interviews
The Value of Biomarkers in MS Patients
- Interviews
Emerging MRI Techniques in MS Patients
- Interviews
Current and Future MS Treatment Options
- Previous
- Next